A study evaluating the efficacy of blocking cell adhesion molecules in vivo found that the combination of the ICAM-1 antibody with the anti-LFA-1 antibody prevented autoimmune lacrimal gland disease in SS model mice (96). Here, ICAM1 is linked to synovial sarcoma.